Tuesday, Feb 4, 2025 · SEC filings

What the smart money revealed on Feb 4

Real insider buys27insiders · $41.4M
Real insider sales78insiders · $25.3M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

1,303 insider filings came in. We hid 119 planned (10b5-1) sellers and 1,061 people whose filings were routine, like grants and tax withholding.

group

3 insiders at Zentalis Pharmaceuticals (ZNTL) bought $177K of stock

Roles: CEO, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jan 31
$177K
trending_up

TKO Group (TKO) CEO Ariel Emanuel bought $39.6M

251,506 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 4 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 4 of 4 beat Traded Jan 31–Feb 4
$39.6M
trending_up

First Busey (BUSE) Director Stephen King bought $403K

16,427 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 31
$403K
trending_up

Texas Capital Bancshares (TCBI) Director Robert Stallings bought $250K

11,788 shares on the open market. Not a grant or an option exercise. Their past buys: 7 of 9 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 7 of 9 beat Traded Jan 31–Feb 3
$250K
trending_up

Franklin Financial Services (FRAF) President Craig Best bought $249K

7,350 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 31
$249K
trending_down

Customers Bancorp (CUBI) Chairman and CEO Jay Sidhu sold $5.71M

Not marked as a planned 10b5-1 sale. Sold 9% of the shares they held directly. Still holds 965,723 shares.

Real sale Form 4 Traded Jan 31–Feb 4
$5.71M
trending_down

McCormick (MKC) Director Lawrence Kurzius sold $3.84M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 276,895 shares directly.

Real sale Form 4 Traded Feb 3
$3.84M
trending_down

J.B. Hunt Transport Services (JBHT) EVP of ICS Eric McGee sold $558K

Not marked as a planned 10b5-1 sale. Sold 80% of the shares they held directly. Still holds 825 shares.

Real sale Form 4 Sold 80% of stake Traded Feb 4
$558K
Show 20 more real buys
BUSE First Busey · Director Stanley Bradshaw · Traded Jan 31–Feb 3
$227K
Invesco Commercial Real Estate Finance Trust · Director James Forson · Traded Feb 3
$100K
FlowStone Opportunity Fund · Secretary Charles Finnegan · Traded Jan 6
$100K
NWBI Northwest Bancshares · Director Mark Paup · Traded Feb 4
$63.3K
FRST Primis Financial · Director John Biagas · Traded Feb 3–4
$44.9K
SMBK Smartfinancial · Chairman of the Board Wesley Welborn · Traded Feb 3
$40.4K
PAAI Arena Group · Director Cavitt Randall · Traded Feb 3
$33.8K
DCOM Dime Community Bancshares · Director Matthew Lindenbaum · Traded Jan 31
$32.6K
CGTX Cognition Therapeutics · CEO and President Lisa Ricciardi · Traded Jan 31
$29.9K
IBKR Interactive Brokers Group · Director Jill Bright · Traded Jan 31
$29.6K
AZTA Azenta · SVP and General Manager Ginger Zhou · Traded Jan 31
$19.1K
UVSP Univest Financial · Director Natalye Paquin · Traded Feb 3
$18.7K
RVP Retractable Technologies · President and CEO Thomas Shaw · Traded Feb 3
$14K
ASRV Ameriserv Financial · President and CEO ASRV and Bank Jeffrey Stopko · Traded Feb 3
$7.86K
MBCN Middlefield Banc · Evp/cfo Michael Ranttila · Traded Feb 3
$7.65K
CZFS Citizens Financial Services · Director John Painter II · Traded Feb 3
$6.6K
MBWM Mercantile Bank · Director Shoran Williams · Traded Jan 31
$6.06K
FNWD Finward Bancorp · President Benjamin Bochnowski · Traded Feb 3
$5.35K
RCG RENN Fund · President and CEO Murray Stahl · Traded Feb 3
$3.43K
NXL Nexalin Technology · Chief Medical Officer David Owens · Traded Feb 4
$2.98K
Show 75 more real sales
OTIS Otis Worldwide · EVP Peiming Zheng · Traded Jan 31
$3.12M
TMUS T-Mobile US · Director Teresa Taylor · Traded Feb 3
$1.89M
EXPE Expedia Group · Director Dara Khosrowshahi · Traded Feb 3
$1.7M
EAT Brinker International · Director Cindy Davis · Traded Feb 3
$1.09M
SANM Sanmina · EVP and Global Sales Charlie Mason · Traded Jan 31
$1.07M
GD General Dynamics · Director Laura Schumacher · Traded Jan 31
$459K
DAL Delta Air Lines · SVP William Carroll · Traded Feb 3
$447K
MIRM Mirum Pharmaceuticals · CEO Christopher Peetz · Traded Feb 3
$439K
AAPL Apple · Director Arthur Levinson · Traded Feb 3
$343K
SANM Sanmina · EVP ALAN REID · Traded Jan 31
$291K
PH Parker-Hannifin · VP and Chief Tech. and Innov. Off. Mark Czaja · Traded Jan 31
$267K
RYTM Rhythm Pharmaceuticals · President and CEO David Meeker · Traded Feb 4
$254K
NTRS Northern Trust · Executive Vice President Jane Karpinski · Traded Feb 3
$252K
EXC Exelon · EVP Compliance David Glockner · Traded Feb 3
$245K
CBSH Commerce Bancshares · Executive Chairman David Kemper · Traded Feb 3
$245K
PLMR Palomar · CEO and Chairman Mac Armstrong · Traded Jan 31
$234K
CPNG Coupang · VP Pranam Kolari · Traded Feb 3
$194K
EVGO EVgo · President Dennis Kish · Traded Feb 3
$151K
OCUL Ocular Therapeutix · Officer Donald Notman · Traded Jan 31–Feb 4
$136K
ACRE Ares Commercial Real Estate · CEO Bryan Donohoe · Traded Jan 31
$133K
HNVR Hanover Bancorp · Director Robert Golden · Traded Jan 31–Feb 3
$127K
MIRM Mirum Pharmaceuticals · President and COO Peter Radovich · Traded Feb 3
$127K
TVTX Travere Therapeutics · CFO Christopher Cline · Traded Feb 3
$104K
TVTX Travere Therapeutics · Chief Commercial Officer Peter Heerma · Traded Feb 3
$104K
RYTM Rhythm Pharmaceuticals · CFO Hunter Smith · Traded Feb 4
$99.7K
NOTV Inotiv · President and CEO Robert Leasure Jr. · Traded Jan 31
$94.2K
RYTM Rhythm Pharmaceuticals · EVP Jennifer Lee · Traded Feb 4
$86K
AMTB Amerant Bancorp · Officer Howard Levine · Traded Jan 31
$83.6K
URGN UroGen Pharma · General Counsel Jason Smith · Traded Jan 31
$82.2K
LEVI Levi Strauss · Director David Friedman · Traded Feb 3
$76.8K
RYTM Rhythm Pharmaceuticals · Chief Technical Officer Joseph Shulman · Traded Feb 4
$76.1K
FFIV F5 · Chief People Officer Lyra Schramm · Traded Feb 1
$75.2K
WM Waste Management · SVP-Chief Information Officer Johnson Varkey · Traded Feb 4
$70.9K
BWFG Bankwell Financial Group · EVP and Chief Risk Officer Steven Brunner · Traded Feb 3
$67.5K
TVTX Travere Therapeutics · SVP Sandra Calvin · Traded Feb 3
$67.4K
UMBF UMB Financial · Director Kevin Gallagher · Traded Feb 3
$60.1K
EXC Exelon · EVP Colette Honorable · Traded Feb 3
$59.4K
CRNC Cerence · Director Thomas Beaudoin · Traded Feb 3
$58.4K
PGY Pagaya Technologies · Chief Development Officer Tami Rosen · Traded Feb 3
$53.6K
RYTM Rhythm Pharmaceuticals · Chief Human Resources Officer Pamela Cramer · Traded Feb 4
$53.6K
MIRM Mirum Pharmaceuticals · SVP Jolanda Howe · Traded Feb 3
$51.3K
URGN UroGen Pharma · Chief Medical Officer Mark Schoenberg · Traded Jan 31
$50.7K
ACRE Ares Commercial Real Estate · Gen. Counsel VP and Secretary Anton Feingold · Traded Jan 31
$43.3K
PLMR Palomar · CFO T. Christopher Uchida · Traded Jan 31
$40.7K
ORI Old Republic International · SVPUnderwriting and Distribution Jeffrey Lange · Traded Jan 31
$40.1K
PLMR Palomar · President Jon Christianson · Traded Jan 31
$37.2K
MASS 908 Devices · President and CEO Kevin Knopp · Traded Feb 3
$37.1K
PAAI Arena Group · Director Christopher Petzel · Traded Feb 3
$33.8K
SEMR SEMrush · General Counsel David Mason · Traded Feb 3
$32.2K
PLMR Palomar · Chief Risk Officer Jonathan Knutzen · Traded Jan 31
$29.5K
PLMR Palomar · Chief Legal Officer Angela Grant · Traded Jan 31
$27.6K
MASS 908 Devices · CFO Joseph Griffith IV · Traded Feb 3
$24K
ACRE Ares Commercial Real Estate · CFO and Treasurer Jeffrey Gonzales · Traded Jan 31
$22.8K
MASS 908 Devices · Chief Legal and Admin Officer Michael Turner · Traded Feb 3
$22.5K
MASS 908 Devices · Chief Product Officer Christopher Brown · Traded Feb 3
$18.2K
AZTA Azenta · VP Violetta Hughes · Traded Feb 3
$16.8K
NOTV Inotiv · Chief Human Resources Officer Jeffrey Krupp · Traded Jan 31–Feb 3
$11.1K
NOTV Inotiv · Chief Strategy Officer John Sagartz · Traded Jan 31
$9.49K
NOTV Inotiv · CFO Beth Taylor · Traded Jan 31
$9.18K
SGRY Surgery Partners · American Group President William Webb · Traded Feb 4
$6.6K
ATYR aTYR Pharma · CFO Jill Broadfoot · Traded Feb 4
$4.74K
SGRY Surgery Partners · Chief Human Resources Officer Danielle Burkhalter · Traded Feb 4
$4.29K
BYFC Broadway Financial · Director Wayne-Kent Bradshaw · Traded Jan 31
$3.47K
ATYR aTYR Pharma · General Counsel Nancy Denyes · Traded Feb 4
$3.4K
JBI Janus International Group · VP Rebecca Castillo · Traded Dec 22
$3.21K
SYBX Synlogic · Officer Mary Dooley · Traded Feb 3
$2.8K
CBUS Cibus · Director Gerhard Prante · Traded Feb 3
$2.77K
VIP Greenidge Generation · President Dale Irwin · Traded Feb 3
$2.68K
VIP Greenidge Generation · CFO Christian Mulvihill · Traded Feb 3
$2.51K
CZFS Citizens Financial Services · Executive Vice President LeeAnn Gephart · Traded Feb 3
$1.45K
LICY Li-Cycle · President and CEO Ajay Kochhar · Traded Jan 31
$1.29K
AXDX Accelerate Diagnostics · CEO Jack Phillips · Traded Feb 3
$655
LICY Li-Cycle · Officer Carl DeLuca · Traded Jan 31
$399
LICY Li-Cycle · CTO Christopher Biederman · Traded Jan 31
$333
LICY Li-Cycle · Chief Commercial Officer Dawei Li · Traded Jan 31
$184

13F season

Holdings as of Dec 31, 2024 are due Feb 14

81 funds have filed so far. 58 filed for the quarter before.

Biggest real insider buys, Jan 29–Feb 4

Open-market buys by officers and directors, filed in the 7 days up to Feb 4.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist